ArticleFrontiers in bioengineering and biotechnology2025
Elastic, load-bearing and autoclavable protein-based graft for coronary revascularization.
Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autologous grafts, such as the internal mammary artery and saphenous vein, are considered the gold standard for coronary artery bypass. However, there is a critical need for small diameter vascular grafts to meet the demands of coronary artery disease patients, as limitations become especially pronounced due to the extremely small caliber of target vessels. Therefore, we designed and manufactured a miniaturized, autoclavable and synthetic-free vascular graft, composed of elastin-like recombinamers hydrogel and native-like silk fibroin textile to ensure an optimal biological integration and mechanical performance, according to ISO 7198 guideline. The construct demonstrated consistent morphological homogeneity and maintained luminal patency throughout its length. The graft was able to replicate the mechanical performance of the autografts in terms of suture retention and compliance and facilitated the formation of an endothelial monolayer, ensuring a physiologically relevant environment prior to implantation. Moreover, the clinical implantation potential was demonstrated by a successful anastomosis to a human vessel
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.